$5.30 0.00% ($0.00)
  • 1D
  • 1W
  • 1M
  • 1Y
  • 5Y
  • YTD

Get ready to invest



NeuroPace, Inc. is a commercial-stage medical device company. The Company is focused on transforming the lives of people suffering from epilepsy by reducing or eliminating the occurrence of debilitating seizures. The Company’s novel and differentiated RNS System is the brain-responsive neuromodulation system that delivers personalized, real-time treatment at the seizure source. The Company’s RNS System is a platform that delivers care for patients suffering from drug-resistant epilepsy and offers a personalized solution and outcomes to the patients suffering from other brain disorders. RNS System is a device that records brain activity data and allows clinicians to monitor patients. RNS System monitors the brain’s electrical activity, recognizes patient-specific abnormal patterns, and delivers treatment at the seizure source. RNS System includes RNS neurostimulator, cortical strip leads, depth leads, patient remote monitor, as well as other implantable and non-implantable accessories.

Stock Analysis

last close $5.12
1-mo return -17.8%
3-mo return -38.8%
avg daily vol. 106.67T
52-week high 25.26
52-week low 4.61
market cap. $132M
forward pe -
annual div. -
roe -
ltg forecast -
dividend yield -
annual rev. $45M
inst own. 90.5%

Subscribe now for daily local and international financial news